Trial intelligence / Profile preview

Longitudinal PET imaging of serotonin transporter occupancy in major depression treated with escitalopram or citalopram

2006-006576-38Phase 4Completed

Sponsor
Medical University of Vienna
Start
Aug 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of escitalopram and citalopram in major depressive disorder (MDD) (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Serotonin transporter occupancy by escitalopram versus citalopram. Started Aug 2007; status: completed.

02

Drugs

escitalopramcitalopram
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on 2006-006576-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-006576-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call